Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 in Huntington's Disease (2CARE)
NCT00608881Phase 3Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2008
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of Coenzyme Q10 mucoadhesive tablets in Huntington's disease (HD), sponsored by Massachusetts General Hospital. Started Mar 2008; status: terminated.
02
Drugs
Coenzyme Q10 mucoadhesive tablets
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00608881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00608881.